Abstract Evidence suggests that the JAK2 V617F mutationis associated with an increased risk of first thrombosisin patients with essential thrombocythemia (ET). Whetherthis mutation is also a risk factor for recurrent thrombosis iscurrently unknown. To investigate the impact of the JAK2V617F mutation on the risk of recurrent thrombosis inpatients with ET, we carried out a multicentre retrospectivecohort study. We recruited 143 patients with previousarterial (64.4%) or venous major thrombosis (34.8%) orboth (0.8%); 98 of them (68.5%) carried the mutation
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V7ì617F mutation / DE STEFANO, V; Za, T; Rossi, E; Vannucchi, Am; Ruggeri, M; Elli, E; Micò, C; Tieghi, A; Cacciola, Rr; Santoro, C; Vianelli, N; Guglielmelli, P; Pieri, L; Scognamiglio, F; Cacciola, Emma; Rodeghiero, F; Pogliani, Em; Finazzi, G; Gugliotta, L; Leone, G; Barbui, T; GIMEMA CHRONIC, Myeloproliferative; NEOPLASMS WORKING, Party. - In: ANNALS OF HEMATOLOGY. - ISSN 0939-5555. - 89(2)(2010), pp. 141-146.
Titolo: | Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation |
Autori interni: | |
Data di pubblicazione: | 2010 |
Rivista: | |
Citazione: | Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V7ì617F mutation / DE STEFANO, V; Za, T; Rossi, E; Vannucchi, Am; Ruggeri, M; Elli, E; Micò, C; Tieghi, A; Cacciola, Rr; Santoro, C; Vianelli, N; Guglielmelli, P; Pieri, L; Scognamiglio, F; Cacciola, Emma; Rodeghiero, F; Pogliani, Em; Finazzi, G; Gugliotta, L; Leone, G; Barbui, T; GIMEMA CHRONIC, Myeloproliferative; NEOPLASMS WORKING, Party. - In: ANNALS OF HEMATOLOGY. - ISSN 0939-5555. - 89(2)(2010), pp. 141-146. |
Handle: | http://hdl.handle.net/20.500.11769/53083 |
Appare nelle tipologie: | 1.1 Articolo in rivista |